A national perspective on prenatal testing for mitochondrial disease

Area of Science:

• Genetics
• Mitochondrial Biology
• Prenatal Diagnostics

Background:

• Mitochondrial diseases, affecting over 1 in 7500 births, stem from mutations in mitochondrial DNA (mtDNA) or nuclear DNA (nDNA).
• Genetic counseling for these families presents unique challenges regarding disease transmission and prevention.
• Prenatal diagnostic testing for mitochondrial diseases has seen increased demand since 2007.

Purpose of the Study:

• To review the reliability and outcomes of prenatal diagnostic testing for mitochondrial diseases.
• To assess the utility of genetic analyses and counseling in preventing disease transmission.
• To evaluate the role of mtDNA heteroplasmy analysis in interpreting test results.

Main Methods:

• Review of diagnostic records for 62 prenatal samples (17 mtDNA, 45 nDNA) analyzed since 2007.
• Analysis of reasons for testing, specific mutations investigated, and clinical outcomes.
• Comparison of prenatal mtDNA heteroplasmy levels with family member data where available.

Main Results:

• Prenatal testing proved reliable and informative for tested nuclear and selected mtDNA mutations.
• mtDNA heteroplasmy analysis in family members aided interpretation of prenatal test results, especially for rare mutations or intermediate heteroplasmy levels.
• Prenatal testing contributed to the prevention of at least 11 cases of mitochondrial disease, including 3 mtDNA-related cases.

Conclusions:

• Prenatal testing for mitochondrial disease is a valuable option for couples seeking to prevent transmission of these genetic disorders.
• Effective genetic analysis and comprehensive pre/post-test counseling are crucial for successful prenatal diagnosis.
• The study highlights the importance of prenatal testing in managing and preventing mitochondrial diseases.